Martin B. Leon, MD

Roxana Mehran , MD;

Gary S. Mintz , MD;

Lowell F. Satler , MD;

Kenneth M. Kent , MD, PhD;

Augusto D. Pichard , MD, FACC, FSCAI;

Martin B. Leon , MD;

Martin Fahy , MSc;

Treatment of Restenotic Drug-Eluting Stents: An Intravascular
Ultrasound Analysis

Dale T. Ashby , MBBS, PhD;

Contrast-induced nephropathy (CIN) may occur after percutaneous coronary interventions (PCI), particularly in patients with baseline chronic renal failure (CRF) and diabetes mellitus.1–3 We have reported on the adverse impact of CIN post-PCI...

Contrast-induced nephropathy...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Koichi Sano , MD, PhD;

Stephane G. Carlier , MD, PhD;

Emilia Solinas , MD;

Jie Qian , MD;

Gary S. Mintz , MD;

Eduardo Missel , MD;

Martin B. Leon , MD;

Roxana Mehran , MD;

Shoujie Shan , MD;

Jeffrey W. Moses , MD;

Theresa Franklin-Bond , MS, PA;

Sirolimus-Eluting Stents for Treatment of Complex Bypass Graft Disease: Insights from the SECURE Registry

Giora Weisz , MD;

Paul Boland , BS;

Michael B. Collins , MD;

Nobuhiko Fujita , MD;

Edward M. Kreps , MD;

Issam Moussa , MD;

Jose de Ribamar Costa Jr., MD, PhD;

Sirolimus-eluting and paclitaxel-eluting stents decrease neointimal hyperplasia leading to a reduction, but not elimination, of in-stent restenosis.1–4 Because sirolimus and paclitaxel decrease neointimal hyperplasia, restenosis is dependent...

Sirolimus-eluting and...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Marco A. Costa , MD, PhD;

Andrew J. Carter , DO, FACC;

Paul S. Teirstein , MD, FACC;

Martin B. Leon , MD;

Martin Zenni , MD;

Theodore A. Bass , MD;

Steven J. Yakubov , MD;

Paul Gilmore , MD;

Jeffrey W. Moses , MD;

Tim A. Fischell , MD, FACC, FSCAI;

Dominick J. Angiolillo , MD, PhD;

Treatment options for bypass graft disease, such as repeat CABG and percutaneous revascularization, are limited and provide disappointing outcomes.1-4 Patients undergoing repeat CABG have over a four times greater rate of mortality compared...

Treatment options for bypass...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

The Relative Effects of Abciximab and Tirofiban on Platelet Inhibition and C-Reactive Protein during Coronary Intervention

01/07/2010

Edward M. Kreps , MD;

Martin B. Leon , MD;

Adam J. Saltzman , MD;

Roxana Mehran , MD;

W. Craig Hooper , PhD;

Jeffrey W. Moses , MD;

Giora Weisz , MD;

Michael B. Collins , MD;

A Multicenter, Randomized, Dose-Finding Study of Gamma Intracoronary Radiation Therapy to Inhibit Recurrent Restenosis after Ste

ABSTRACT: Background. We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI). Methods....

ABSTRACT: Background. We sought...

01/07/2010

Journal of Invasive Cardiology

08/01/2008

Roberto Lipsztein , MD;

Prabhakar Tripuraneni , MD;

Paul S. Teirstein , MD, FACC;

Martin B. Leon , MD;

Gender Differences in Long-Term Clinical Outcomes After Percutaneous Coronary Intervention of Chronic Total Occlusions

Manuela Negoita , MD;

Huan Giap , MD;

Ray Lin , MD;

Stephen Balter , PhD;

Roxana Mehran , MD;

Shirish Jani , PhD;

Matthew J. Price , MD;

Jeffrey W. Moses , MD;

Stephen Steuterman , MS;

Michael B. Collins , MD;

Jack Dalton , MD;

Intracoronary radiation therapy (ICRT) for in-stent restenosis within bare metal stents substantially reduces the risk of recurrence.1–3 However, target vessel failure remains a significant clinical problem for some patients. A higher...

Intracoronary radiation therapy...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

10/01/2012

Jose P.S. Henriques , MD, PhD;

Roxana Mehran , MD;

Alaide Chieffo , MD;

Jeffrey W. Moses , MD;

Seung-Whan Lee , MD, PhD;

Seung-Jung Park , MD, PhD;

Mauro Carlino , MD;